The Washington Post reports that the pharmaceutical industry is making a major lobbying push to derail a proposal that would allow the United States to import U.S.-approved medications from Canada, Europe, Australia, New Zealand and Japan, where drug prices are much cheaper because of price controls.

Public Campaign Action Fund's Campaign Money Watch has released a new television ad about Stevens' campaign contributions from the pharmaceutical industry and how he carries water for them in the Senate.

According to the House Oversight and Government Reform Committee, Medicare Part D makes terrific financial sense...for pharmaceutical companies. A report from the committee shows a $3.7 billion profit in the last two years for pharmaceutical companies due to more favorable reimbursements under Part D -- not a bad return on investment for the $36 million the industry has poured into campaign coffers in that same time period, according to the Center for Responsive Politics.